Triphenylphosphonium (TPP)-Based Antioxidants: A New Perspective on Antioxidant Design

Area of Science:

• Biochemistry
• Cell Biology
• Pharmacology

Background:

• Mitochondrial oxidative damage and dysfunction are implicated in numerous human diseases.
• Conventional antioxidants have limitations in effectively targeting mitochondria, the primary source of reactive oxygen species (ROS).

Purpose of the Study:

• To review the deficiencies of conventional antioxidants.
• To highlight the advantages of mitochondria-targeted antioxidants.
• To discuss various types of triphenylphosphonium (TPP)-based mitochondria-targeted antioxidants.

Main Methods:

• Literature review of TPP-based mitochondria-targeted antioxidants.
• Discussion of TPP moiety's role in achieving high mitochondrial concentration.
• Analysis of cell and mitochondrial membrane potentials' influence on antioxidant accumulation.

Main Results:

• Triphenylphosphonium (TPP) as a lipophilic cation facilitates targeted delivery of antioxidants to mitochondria.
• TPP-conjugated antioxidants achieve over 1000-fold higher mitochondrial concentrations.
• Mitochondria-targeted antioxidants show potential in preventing various cell death pathways.

Conclusions:

• Mitochondria-targeted antioxidants, particularly TPP-based ones, represent a promising strategy to combat oxidative stress-related diseases.
• The design principles discussed provide a foundation for developing novel and more effective antioxidant therapies.
• Further research into TPP-based antioxidants could lead to significant advancements in treating mitochondrial dysfunction-associated pathologies.